Glucagon Kit
Product Images NDC 0548-5850

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 0548-5850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Glucagon Figure1a)

A line graph depicting glucagon concentration (ng/mL) over time (hours) following dosing. The x-axis represents time from dosing up to 5 hours, while the y-axis shows glucagon concentrations ranging from 0 to 10 ng/mL. Data points indicate a peak concentration shortly after dosing followed by a decline over time, with error bars at each point.*

FDA Label Image

Figure 1b (Glucagon Figure1b)

A line graph depicting blood glucose concentrations in mg/dL over a 4-hour time span in hours. The graph shows an initial increase in glucose levels, peaking between 0.5 and 1 hour, followed by a gradual decrease and stabilization near baseline from about 1.5 to 4 hours.*

FDA Label Image

Instructions 1 (Glucagon Instructions1)

An instructional diagram showing a hand holding a small vial or container, with an arrow pointing upward indicating the direction to pull or remove the cap or stopper. The illustration likely demonstrates part of the process for preparing or using the Glucagon kit by Amphastar Pharmaceuticals.*

FDA Label Image

Instructions 2 (Glucagon Instructions2)

An instructional line drawing showing a hand drawing liquid from a vial into a syringe. The vial is held with one hand, while the other hand pulls back the syringe plunger. A bold arrow points downward toward the syringe, indicating the direction of drawing medication from the vial.*

FDA Label Image

Instructions 3 (Glucagon Instructions3)

An instructional line drawing showing a hand holding a vial or small container and rotating it in a circular motion, indicated by a curved arrow around the container. This suggests an action of mixing or shaking the contents before use.*

FDA Label Image

Instructions 4 (Glucagon Instructions4)

An instructional illustration showing a hand holding a vial and syringe, with an arrow indicating the motion of drawing liquid from the vial into the syringe. The image demonstrates proper technique for preparing an injection, relevant for Glucagon kit usage.*

FDA Label Image

Kit Label (Glucagon Kit Pdp)

Glucagon Emergency Kit packaging label by Amphastar Pharmaceuticals, Inc., for injection 1 mg per vial and diluent in a 1 mL syringe. The label is predominantly red with white text, featuring product usage instructions for low blood sugar and including manufacturer details and an NDC code.*

FDA Label Image

Sequence (Glucagon Sequence)

Chemical structure diagram showing the amino acid sequence of glucagon. The sequence is presented in a curved layout with each amino acid labeled by its three-letter abbreviation and corresponding position number, starting with Histidine (His) at position 1 and ending with Threonine (Thr) at position 29.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.